Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rikke S Møller

Showing results (1-10 of 253) with videos related to

Pageof 26
Sort By:
Epilepsia|January 7, 2020
Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomesElena Gardella, Rikke S Møller
Ebiomedicine|July 24, 2020
The impact of low-risk genetic variants in self-limited epilepsy with centrotemporal spikes aka Rolandic epilepsyThomas F Hansen, Rikke S Møller
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 11, 2015
Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel BlockersRikke S Møller, Katrine M Johannesen
The Lancet. Neurology|August 18, 2023
Genome sequencing for the fast diagnosis of early-onset epilepsiesKatrine M Johannesen, Rikke S Møller
Brain : a Journal of Neurology|October 31, 2019
The first step towards personalized risk prediction for common epilepsiesThomas F Hansen, Rikke S Møller
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 1, 2020
Recent advances in treatment of epilepsy-related sodium channelopathiesElisa Musto, Elena Gardella, Rikke S Møller
Epilepsia|March 18, 2015
The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009Allan Bayat, Helle Hjalgrim, Rikke S Møller
Epilepsia|August 13, 2020
Genetic testing in adult epilepsy patients: A call to action for cliniciansGuido Rubboli, Rikke S Møller, Katrine M Johannesen
Expert Review of Molecular Diagnostics|November 14, 2015
The contribution of next generation sequencing to epilepsy geneticsRikke S Møller, Hans A Dahl, Ingo Helbig
Genes|August 6, 2021
Epilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision TherapyAllan Bayat, Michael Bayat, Guido Rubboli, et al.
Pageof 26

Showing results (1-10 of 253) with videos related to

Sort By:
Pageof 26
Epilepsia|January 7, 2020
Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomesElena Gardella, Rikke S Møller
Ebiomedicine|July 24, 2020
The impact of low-risk genetic variants in self-limited epilepsy with centrotemporal spikes aka Rolandic epilepsyThomas F Hansen, Rikke S Møller
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 11, 2015
Precision Medicine: SCN8A Encephalopathy Treated with Sodium Channel BlockersRikke S Møller, Katrine M Johannesen
The Lancet. Neurology|August 18, 2023
Genome sequencing for the fast diagnosis of early-onset epilepsiesKatrine M Johannesen, Rikke S Møller
Brain : a Journal of Neurology|October 31, 2019
The first step towards personalized risk prediction for common epilepsiesThomas F Hansen, Rikke S Møller
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 1, 2020
Recent advances in treatment of epilepsy-related sodium channelopathiesElisa Musto, Elena Gardella, Rikke S Møller
Epilepsia|March 18, 2015
The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009Allan Bayat, Helle Hjalgrim, Rikke S Møller
Epilepsia|August 13, 2020
Genetic testing in adult epilepsy patients: A call to action for cliniciansGuido Rubboli, Rikke S Møller, Katrine M Johannesen
Expert Review of Molecular Diagnostics|November 14, 2015
The contribution of next generation sequencing to epilepsy geneticsRikke S Møller, Hans A Dahl, Ingo Helbig
Genes|August 6, 2021
Epilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision TherapyAllan Bayat, Michael Bayat, Guido Rubboli, et al.
Pageof 26